Phase I clinical and pharmacokinetic study of perillyl alcohol administered four times a day.
Ripple GH, Gould MN, Arzoomanian RZ, Alberti D, Feierabend C, Simon K, Binger K, Tutsch KD, Pomplun M, Wahamaki A, Marnocha R, Wilding G, Bailey HH.
Ripple GH, et al. Among authors: bailey hh.
Clin Cancer Res. 2000 Feb;6(2):390-6.
Clin Cancer Res. 2000.
PMID: 10690515
Clinical Trial.